Eton Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €192.75M +17.0% €69.71M +23.2% 36.2% +0.018 pp N/A N/A
    (estimated) €164.71M +33.6% €56.57M +54.5% 34.3% +0.047 pp N/A N/A
    (estimated) €123.32M +30.3% €36.61M +48.7% 29.7% +0.037 pp €38.61M +59.9% 31.3% +0.058 pp
    (estimated) €94.65M +40.8% €24.61M +527.7% 26.0% +0.20 pp €24.14M +63.0% 25.5% +0.035 pp
    (estimated) €67.20M +101.2% €3.92M -219.8% 5.8% +0.16 pp €14.81M +1,638.7% 22.0% +0.19 pp
    €33.40M +23.3% -€3.27M +308.4% -9.8% -0.068 pp €851.81K -86.9% 2.6% -0.21 pp
    €27.09M +48.9% -€801.30K -90.4% -3.0% +0.43 pp €6.50M -0.2% 24.0% -0.12 pp
    €18.19M -2.7% -€8.37M +230.4% -46.0% -0.32 pp €6.51M -620.5% 35.8% +0.43 pp
    €18.69M +55,879.5% -€2.53M -89.7% -13.6% +740 pp -€1.25M -93.4% -6.7% +570 pp
    €33.39K -95.9% -€24.68M +59.8% -73,920.5% -720 pp -€19.09M +37.8% -57,169.2% -550 pp
    €820.99K +∞% -€15.44M +41.6% -1,881.0% -19 pp -€13.85M +104.6% -1,687.2% -17 pp
    €0.00 +NaN% -€10.91M +78.0% N/A -€6.77M +72.4% N/A
    €0.00 -€6.13M N/A -€3.93M N/A

    Notifications